Exempting law enforcement agencies who do not provide emergency opioid antagonistspursuant to the statewide protocol from the requirement to procure a physician medical director.
Impact
The implications of HB2159 are significant, particularly as it removes law enforcement agencies from the state board of pharmacy's statewide opioid antagonist protocol. This change is intended to facilitate better access to emergency opioid antagonists without the layers of bureaucratic oversight that may delay access in emergency situations. By providing a financial framework and resources to law enforcement, the bill aims to enhance immediate response efforts in overdose situations, potentially reducing mortality rates associated with opioid overdoses.
Summary
House Bill 2159 aims to establish the emergency opioid antagonists assistance grant fund to support law enforcement agencies in purchasing emergency opioid antagonists. This initiative is designed to enhance the readiness and capability of law enforcement officials to respond to opioid overdoses effectively. The bill mandates an annual transfer of $4,000,000 from the state general fund to the newly created grant fund, prioritizing smaller law enforcement agencies in the distribution of resources needed to obtain these critical life-saving medications.
Contention
Some notable points of contention regarding HB2159 may arise from its exclusion of law enforcement agencies from certain regulatory protocols. Advocates for stronger regulatory measures may argue that this could lead to inconsistencies in how emergency opioid antagonists are administered across different jurisdictions. Furthermore, the allocation of state funds primarily to small law enforcement agencies could raise questions about equity and the effectiveness of resource distribution among various agencies that are tackling the opioid crisis.
House Substitute for SB 287 by Committee on Health and Human Services - Prohibiting a healthcare provider from administering medication, diagnostic tests or conducting ongoing behavioral health treatments to a minor in a school facility without parental consent, enacting the no patient left alone act to require medical care facilities to allow in-person visitation in certain circumstances, expanding licensure of rural emergency hospitals that meet criteria between January 2015 and December 2020 and authorizing emergency medical responders to distribute non prescription over-the-counter medications.
House Substitute for HB 2390 by Committee on Public Health and Welfare - Requiring the secretary of health and environment to study drug overdose death cases and providing for the confidentiality of acquired and related records, restricting the authority of the secretary of health and environment and local health officers to prevent the introduction and spread of infectious or contagious diseases and repealing the authority of the secretary to quarantine individuals and impose associated penalties.
House Substitute for SB 42 by Committee on Appropriations - Exempting rural emergency hospitals from the hospital provider assessment and establishing residency and other requirements for membership on a hospital board.
Enacting the forbidding abuse child transitions act, restricting use of state funds to promote gender transitioning, prohibiting healthcare professionals from treating children whose gender identity is inconsistent with the child's sex, authorizing a civil cause of action against healthcare professionals for providing such treatments, authorizing professional discipline against a physician who performs such treatment, prohibiting professional liability insurance from covering damages for healthcare providers that provide gender transition treatment to children and adding violation of the act to the definition of unprofessional conduct for physicians and nurses.
House Substitute for SB 233 by Committee on Health and Human Services - Enacting the forbidding abuse child transitions act, restricting use of state funds to promote gender transitioning, prohibiting healthcare providers from treating children whose gender identity is inconsistent with the child's sex, authorizing a civil cause of action against healthcare providers for providing such treatments, requiring professional discipline against a healthcare provider who performs such treatment, prohibiting professional liability insurance from covering damages for healthcare providers that provide gender transition treatment to children and adding violation of the act to the definition of unprofessional conduct for physicians and nurses.
Defining primary aggressor for domestic violence purposes and requiring law enforcement policies to direct that arrest is the preferred response only with respect to the primary aggressor.
Prohibiting abortion procedures except when necessary to save the life of the pregnant woman and providing a private cause of action for civil enforcement of such prohibition.
Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.